Does BEPRIDIL Cause Interstitial lung disease? 20 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Interstitial lung disease have been filed in association with BEPRIDIL. This represents 24.4% of all adverse event reports for BEPRIDIL.
20
Reports of Interstitial lung disease with BEPRIDIL
24.4%
of all BEPRIDIL reports
4
Deaths
15
Hospitalizations
How Dangerous Is Interstitial lung disease From BEPRIDIL?
Of the 20 reports, 4 (20.0%) resulted in death, 15 (75.0%) required hospitalization, and 3 (15.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEPRIDIL. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does BEPRIDIL Cause?
Electrocardiogram qt prolonged (8)
Atrial fibrillation (7)
Bradycardia (6)
Torsade de pointes (6)
Diarrhoea (5)
Drug-induced liver injury (5)
Renal impairment (5)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)